Neil Poulsen
Vascular Surgery · Rockaway, NJNPI 1841610821
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (50.4%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Cagent Vascular Inc at 37.9% of the total. 2025 is the largest year on record at $85,382, more than ten times the $308 reported in 2019. Among vascular surgery clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 467 payments — averaging $316.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cagent Vascular Inc$56K
- Shockwave Medical, Inc$43K
- Penumbra, Inc.$19K
- Medtronic$15K
- Silk Road Medical, Inc.$2K
- Philips North America LLC$2K
- plus $11K from 27 others
What the payments were for
- Consulting fees$74,39850%
- Speaking & faculty fees$28,65019%
- Grants$9,0006%
- Travel & lodging$9,1376%
- Food & beverage$25,89918%
- Education$5650%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cagent Vascular Inc | 48 | $56,004 |
| Shockwave Medical, Inc | 51 | $43,225 |
| Penumbra, Inc. | 55 | $18,688 |
| Medtronic(2 entities) | 113 | $14,644 |
| Silk Road Medical, Inc. | 15 | $1,916 |
| Philips North America LLC | 13 | $1,764 |
| Boston Scientific | 43 | $1,598 |
| Endologix LLC | 6 | $1,480 |
| W. L. Gore & Associates, Inc. | 17 | $1,305 |
| Inari Medical, Inc. | 15 | $1,145 |
| Cardiovascular Systems Inc. | 13 | $1,132 |
| Convatec Inc. | 19 | $753 |
| Bolton Medical Inc | 6 | $675 |
| Cook Medical LLC | 6 | $508 |
| Kerecis Limited | 6 | $392 |
| Tactile Systems Technology Inc | 4 | $309 |
| Limflow Inc. | 2 | $301 |
| Acera Surgical, Inc. | 3 | $300 |
| Bard Peripheral Vascular, Inc. | 3 | $246 |
| Abbott | 2 | $207 |
| Angiodynamics, Inc. | 3 | $207 |
| Biom'up France SAS | 2 | $204 |
| Sanara Medtech Inc. | 1 | $150 |
| Stryker | 5 | $132 |
| Lemaitre Vascular, Inc. | 5 | $101 |
| Venturemed Group, Inc. | 1 | $70 |
| Merck | 3 | $42 |
| Terumo Medical Corporation | 1 | $35 |
| Pfizer | 2 | $32 |
| Organogenesis Inc. | 1 | $26 |
| Baxter Healthcare | 1 | $25 |
| Solventum Corporation | 1 | $18 |
| Integra Lifesciences Corporation | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Serrantor$55,600
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$42,626
- Indigo System$14,529
- Endurant$9,565
- RUBY Coil$3,164
- ENROUTE Transcarotid Neuroprotection System$3,145
- ENDURANT IIS$1,955
- ENROUTE Transcarotid Stent$1,807
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$1,338
- ENDOCROSS Device$1,215
- Torus Stent Graft System$1,215
- (9520) IGT Devices Undivided$1,200
- FLOWTRIEVER CATHETER, S$976
- CT THROMBECTOMY SYSTEM KIT$976
- Kerecis Omega3 SurgiClose$817
- HawkOne$744
- Diamondback Peripheral$651
- GORE VIABAHN VBX Balloon Expandable Endo$535
- InnovaMatrix AC$415
- GORE VIABAHN Endoprosthesis with Heparin$374
How this compares
$147,650 in reported general payments places this provider in the 95th percentile of 182 vascular surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 14 | $16,962 |
| ClopidogrelClopidogrel Bisulfate | 38 | $476 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $32 | $16,96214 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 182 vascular surgery providers in New Jersey.
Other vascular surgery in Rockaway
- Steven EliasEnglewood$509K
- Michael WildermanHackensack$383K
- David O'ConnorHackensack$272K
- Joseph LombardiPomona$266K
- William BeckermanNew Brunswick$176K
- Massimo NapolitanoWayne$147K
- Laurel HastingsCamden$98K
- Danielle PinedaPomona$97K
- Saum RahimiNew Brunswick$90K
- Michael LiebHainesport$76K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.